Skip to main content

Prostate cancer treatment cost in Thailand

Prostate cancer treatment cost in Thailand by risk group, treatment intent, and recovery

A prostate cancer estimate should begin with PSA, multiparametric MRI, biopsy grade and cores, clinical stage, lymph-node or bone findings, life expectancy, urinary function, sexual priorities, and the patient’s goals. Thailand can offer surgery, image-guided radiation, brachytherapy, hormone treatment, chemotherapy, and newer systemic care, but the quote must show whether it is for localized cure, recurrence control, or metastatic disease and how follow-up will continue at home.

How much does prostate cancer treatment cost in Thailand?

Localized prostatectomy in Thailand may be budgeted at THB 495,000 to 1,155,000, about USD 15,000 to 35,000, when the case has a defined surgical plan and routine admission. Radiation with hormone treatment and follow-up may range from THB 825,000 to 2,310,000, around USD 25,000 to 70,000. Metastatic or recurrent disease using long-term hormone therapy, chemotherapy, radioligand or newer medicines can reach THB 1,320,000 to 4,950,000+, roughly USD 40,000 to 150,000+. The treating team must convert the estimate into a patient-specific plan.

USD illustrations use approximately THB 33 per USD, based on the Bank of Thailand exchange-rate context checked in July 2026. Drug, implant, radiation, and robotic-system quotes may use different currencies. Ask which currency controls the deposit, medicine supply, exchange adjustment, and final bill.

Let Us Help You

Share the basics and the Virello team will guide you toward the next step.

Prefer email? Write to support@virellohealth.com.

Reviewed 2026-07-19

Clinical review: Virello Health Clinical Content Team · Editorial review: Virello Health Research Team

Billing context: THB and USD

Risk group directs treatment

Grade Group, PSA, tumor stage, MRI, cores, and spread determine whether surveillance, surgery, radiation, or systemic treatment is reasonable.

Recovery priorities differ

Urinary continence, erections, bowel effects, fertility, and testosterone recovery should be discussed before choosing a route.

Robotic is not a guarantee

Robotic surgery may change access and recovery but does not remove cancer, urinary, sexual, bleeding, or anesthesia risks.

Hormone treatment is ongoing

Injections or tablets may continue for months or years and require metabolic, bone, cardiovascular, and symptom monitoring.

PSA follow-up is essential

A successful trip includes a PSA schedule, pathology report, treatment summary, and an identified urologist or oncologist at home.

Cost at a glance

Planning scenarios for prostate cancer treatment in Thailand

The scenarios separate routine and complex pathways. They are not fixed packages and should be replaced by a report-led hospital estimate before travel.

Estimated prostate cancer treatment cost scenarios in Thailand
ScenarioTHBUSDPatient and treatment contextPlanning scope
Localized surgery pathwayTHB 495,000 - 1,155,000USD 15,000 - 35,000Biopsy-confirmed localized disease proceeding to open, laparoscopic, or robotic prostatectomy with routine lymph-node assessment where indicated.Name MRI review, surgeon, anesthesia, robotic or laparoscopic system, pathology, room, catheter, continence teaching, and early review.
Radiation and hormone pathwayTHB 825,000 - 2,310,000USD 25,000 - 70,000Intermediate or high-risk localized or locally advanced disease treated with external radiation, brachytherapy, hormone treatment, or a combination.Include planning, image guidance, fractions or implants, hormone injections or tablets, blood tests, side-effect review, and duration.
Recurrent or metastatic careTHB 1,320,000 - 4,950,000+USD 40,000 - 150,000+Biochemical recurrence, metastatic hormone-sensitive disease, castration-resistant cancer, painful bone disease, or long-term systemic treatment.Budget by named medicine, scan schedule, bone protection, chemotherapy or radioligand access, and response-dependent continuation.

Usually included

Check the clinical package scope

Urology and oncology review

PSA history, MRI, biopsy, grade group, stage, urinary and sexual function, comorbidities, and treatment goals are reviewed.

Send pathology and MRI source data before travel.

Defined local treatment

Prostatectomy, radiation, brachytherapy, or focal treatment only when the exact procedure and equipment are named.

Robotic, navigation, implant, and image-guidance assumptions need writing.

Systemic phase if quoted

Hormone injection, tablet, chemotherapy, bone medicine, or another named treatment with dose and interval.

A first injection is not a full hormone course.

Discharge and PSA handover

Catheter or bowel instructions, pathology, medicine plan, PSA dates, pelvic-floor advice, and home clinician communication.

Sexual and continence rehabilitation may be separate.

Confirm separately

Charges that may sit outside the range

Advanced imaging and pathology

Repeat MRI, PSMA PET, outside slide review, genomic testing, node pathology, or additional biopsy.

Confirm which test changes management.

Equipment and implants

Robotic consumables, brachytherapy seeds, spacer, fiducials, specialized radiation, penile prosthesis, or urinary device unless stated.

Device brand and warranty should be visible.

Ongoing medicines

Hormone injections, anti-androgens, chemotherapy, steroids, bone agents, pain medicines, and treatment for side effects.

Ask for a monthly or cycle-based forecast.

Complications and home care

Bleeding, infection, leak, clot, retention, incontinence, erectile treatment, bowel injury, fracture, admission, and hotel extension.

Keep a reserve for delayed recovery.

Candidate context

Who may be considered and what else may be discussed

The treatment decision should follow life expectancy, overall health, PSA trend, MRI, biopsy grade group, tumor volume, local extension, lymph nodes, bone or visceral spread, urinary baseline, sexual priorities, fertility, and willingness to complete surveillance. Active surveillance can be appropriate for selected lower-risk disease. Surgery or radiation may be curative for localized disease. Hormone treatment, chemotherapy, radioligand treatment, targeted medicine, and bone protection may be used when disease has returned or spread. Thailand should be considered only after a named urology-oncology team reviews the complete record.

Information that shapes suitability

Reliable risk classification

Biopsy grade, positive cores, PSA density, MRI lesion, clinical stage, and selected genomic evidence help separate low, intermediate, and high risk.

Surgical fitness

Heart, lungs, kidney function, obesity, anticoagulation, prior pelvic surgery, bowel disease, and anesthesia risk affect prostatectomy.

Radiation suitability

Urinary symptoms, prostate size, prior pelvic radiation, bowel disease, hip hardware, and ability to attend planned sessions influence the choice.

Metastatic assessment

PSMA PET, CT, MRI, bone imaging, symptoms, alkaline phosphatase, and organ function may be needed before systemic care.

Recovery goals

Continence, erections, fertility, bowel function, work, exercise, and long-term medicine access should be in the care plan.

Alternatives or sequencing questions

Active surveillance

Selected lower-risk patients may monitor PSA, MRI, examination, and repeat biopsy instead of immediate treatment.

Prostatectomy

Open, laparoscopic, or robotic removal may be used for selected localized disease with pelvic-node assessment when indicated.

Radiation and brachytherapy

External-beam, stereotactic, or implant radiation can be chosen according to risk, anatomy, urinary function, and local expertise.

Hormone and systemic treatment

Androgen-deprivation, androgen-receptor medicines, chemotherapy, bone treatment, and selected advanced therapies can control recurrent or metastatic disease.

Procedure variations

Why the named procedure does not have one price

Technique, device, medicine, treatment extent, and prior care can change both the clinical plan and the estimate.

Robotic prostatectomy

Minimally invasive removal with pelvic reconstruction and possible node dissection.

Ask about surgeon volume, conversion, catheter duration, pathology, and continence pathway.

External-beam radiation

Precisely planned fractions treat the prostate and selected nodes over a schedule set by risk.

Planning, image guidance, fractions, and bowel or bladder support must be priced.

Brachytherapy

Radioactive seeds or a temporary source delivers treatment inside or near the prostate.

Include anesthesia, implants, urinary monitoring, and radiation-safety instructions.

Hormone plus radiation

Androgen deprivation may start before, continue during, and follow radiation.

State injection, tablet, interval, months, bone, metabolic, and cardiovascular monitoring.

Metastatic systemic care

Hormone-sensitive or resistant disease may need layered medicines, chemotherapy, bone agents, or another specialist treatment.

Progression can change the drug and budget.

City comparison

Cost and capability by city in Thailand

Only cities with evidence for the procedure should appear here. A city range does not prove that every hospital in that city can manage the same case complexity.

Estimated prostate cancer treatment costs and planning context by city in Thailand
CityLocal rangeUSD rangeCapability contextStay planning
BangkokTHB 561,000 - 4,950,000+USD 17,000 - 150,000+Broad access to robotic urology, radiation planning, nuclear medicine, pathology, and medical oncology.Confirm PSMA PET, brachytherapy, named surgeon, medicine stock, and home PSA handover.
Chiang MaiTHB 528,000 - 4,290,000+USD 16,000 - 130,000+University and private services may offer prostate surgery, radiation, and systemic follow-up.Check advanced imaging and escalation arrangements for recurrence or complications.
PhuketTHB 561,000 - 4,125,000+USD 17,000 - 125,000+International coordination is strong, with specialist depth dependent on the named hospital.Do not select a resort location before confirming urology and oncology capability.
Pattaya and Chon BuriTHB 528,000 - 3,795,000+USD 16,000 - 115,000+Selected eastern hospitals provide urology, radiation, or medicine services.Verify whether complex surgery and radiation happen locally or require Bangkok travel.
Khon KaenTHB 495,000 - 3,630,000+USD 15,000 - 110,000+Regional tertiary care may suit planned surgery or standard radiation for appropriate patients.Include pathology, imaging, hormone supply, and urinary complication plans.
Hat Yai and SongkhlaTHB 495,000 - 3,630,000+USD 15,000 - 110,000+Southern regional services can support selected urology and oncology pathways.Ask about catheter problems, retention, infection, and emergency admission.
Nakhon RatchasimaTHB 495,000 - 3,300,000+USD 15,000 - 100,000+A large regional route may offer value for surgery, hormone injections, and follow-up.A specialist referral for high-risk or metastatic disease should be documented.
Chiang RaiTHB 495,000 - 3,135,000+USD 15,000 - 95,000+Regional urology assessment is possible, with advanced imaging and therapies varying by center.Confirm where PSMA imaging and radiation are performed.
Udon ThaniTHB 478,500 - 3,135,000+USD 14,500 - 95,000+Planned urology procedures and stable treatment may be feasible in selected centers.Clarify long-term hormone supply and PSA reporting.
RayongTHB 495,000 - 3,465,000+USD 15,000 - 105,000+Eastern transport access can help selected planned prostate care.Travel convenience should follow a complete treatment and recovery pathway.

Estimate variables

What can change the final hospital cost

Risk group and intent

Surveillance, localized cure, biochemical recurrence, hormone-sensitive spread, and resistant disease require different resources.

Ask the team to state treatment intent.

Imaging and pathology

MRI, PSMA PET, biopsy review, genomic tests, node sampling, and stage work alter the decision and initial bill.

Do not compare a surgery quote with a fully staged plan.

Technique and equipment

Robotic system, open or laparoscopic access, brachytherapy, fiducials, spacer, and image guidance have different costs.

Name every device and consumable.

Hormone and advanced drugs

Injection interval, oral agent, chemotherapy, bone agent, radioligand, dose, and months of treatment drive recurring cost.

Request a six- or twelve-month scenario.

Functional recovery

Catheter, incontinence, erectile dysfunction, bowel symptoms, infection, pelvic-floor therapy, and prosthetic treatment can add care.

Recovery should be priced as a separate phase.

Medical cost breakdown

Before admission, in hospital, and after discharge

Diagnostics and preparation

Prostate diagnosis

PSA trend, examination, MRI, targeted or systematic biopsy, pathology, grade group, and tissue review.

MRI source images and pathology details improve review.

Stage assessment

CT, bone scan, PSMA PET, MRI pelvis, or other imaging selected for risk and symptoms.

Ask what each scan will change.

Treatment fitness

Blood count, kidney and liver function, ECG, anesthesia review, urinary score, sexual function, and bone or metabolic baseline.

Some tests are repeated locally before treatment.

Admission and treatment

Prostatectomy admission

Anesthesia, operation, robotic or laparoscopic equipment, catheter, pathology, room, medicines, mobilization, and discharge review.

Ask about node dissection and unexpected conversion.

Radiation preparation

Simulation, fiducials, spacer, contouring, planning, physics checks, image guidance, fractions, and reviews.

Price the complete course rather than a daily rate only.

Systemic day care

Hormone injection, drug administration, laboratory checks, infusion, chemotherapy, bone medicine, or observation.

Pharmacy supply and administration should be separate lines.

Recovery and follow-up

Catheter and pelvic recovery

Catheter removal, urine leakage education, pelvic-floor training, wound care, pain control, and urinary review.

Retention, infection, or leak can change the stay.

Radiation effects

Urinary frequency, bowel irritation, fatigue, erectile changes, medication, and follow-up review.

Ask who manages late symptoms.

Long-term cancer surveillance

PSA, testosterone, imaging, hormone side-effect care, bone health, cardiovascular review, and recurrence management.

Plan home testing before leaving Thailand.

Complete journey budget

Plan beyond the hospital invoice

Patient and attendant costs should be modeled separately from the medical estimate, with flexible dates and a contingency reserve.

Pre-travel records

PSA table, MRI, biopsy, grade group, scans, urinary and sexual scores, medicines, and hospital acceptance.

Include fertility or continence priorities.

Treatment and stay

Admission, catheter or radiation visits, housing, companion, transport, translation, medicines, and extra nights.

Radiation attendance may make a nearby room essential.

Return and monitoring

Fit-to-fly, catheter plan, PSA schedule, prescription supply, pelvic-floor rehabilitation, and urologist handover.

A treatment summary is needed before travel home.

Country access

Rules and practical requirements to verify

Visa, donor, fertility, medicine, licensing, and treatment-access requirements can change. Confirm current rules with the relevant authority and treating hospital.

Verify the named hospital

Use Thailand Medical Hub and the hospital international department to confirm the urology, radiation, nuclear medicine, and oncology services.

Ask about device and medicine authorization

Confirm robotic consumables, brachytherapy materials, PSMA imaging access, hormone products, and advanced medicines in writing.

Check radiation quality

Request the radiation oncologist, physicist, machine, planning process, image guidance, and backup schedule.

Protect pathology and privacy

Agree release, courier, tissue review, translation, consent, records access, and return of slides or blocks.

Use official travel guidance

Check the Thailand e-Visa portal or relevant embassy and allow for catheter, radiation, or treatment delays.

Hospital selection

Compare capability before package price

Urology-oncology team

Urologist, uropathologist, radiologist, radiation oncologist, medical oncologist, nuclear medicine, anesthetist, and rehabilitation.

Ask whether the case is discussed as one pathway.

Pathology and imaging

MRI, biopsy review, grade group, node and margin reporting, PSMA PET or other stage imaging, and record transfer.

A high-risk decision needs complete evidence.

Treatment equipment

Robotic or laparoscopic system, radiation planning, brachytherapy, fiducials, spacer, and emergency urologic support.

Confirm what is actually onsite.

Functional recovery

Catheter, continence, pelvic floor, erectile function, bowel symptoms, infection, pain, and psychosocial support.

Outcomes should be discussed without guarantees.

Long-term supply

Hormone injections, oral drugs, PSA testing, scans, bone care, and home clinician communication.

Avoid a plan that ends at discharge.

Treating team

Specialists and support that may matter

Urologic surgeon

Interprets anatomy, chooses access, discusses nerve-sparing limits, removes the prostate when indicated, and manages urinary complications.

Uropathologist

Reports grade, margins, nodes, extracapsular extension, seminal vesicles, and the findings that shape further treatment.

Radiation oncologist

Plans external or implant radiation, image guidance, dose constraints, bladder and bowel preparation, and follow-up.

Medical oncologist or nuclear medicine specialist

Manages hormone therapy, chemotherapy, advanced medicines, bone protection, and selected radioligand treatment.

Pelvic rehabilitation team

Supports catheter care, continence, pelvic-floor strength, sexual recovery, nutrition, and safe activity.

Treatment timeline

From report review to return-home follow-up

Remote urology review

Share PSA history, MRI, biopsy, grade group, stage scans, urinary and sexual function, medicines, and priorities.

Risk confirmation

The Thai team confirms stage, resectability, need for PSMA imaging, treatment intent, and options with expected trade-offs.

Local treatment

Surgery, radiation, brachytherapy, surveillance, or systemic treatment starts after consent and safety tests.

Early recovery or monitoring

Catheter, wound, urinary, bowel, pain, hormone, or radiation reviews determine the next safe step.

Ongoing treatment

Hormone injections, tablets, chemotherapy, scans, PSA, and side-effect support continue according to risk and response.

Home handover

Receive operative and pathology reports, PSA and testosterone schedule, prescriptions, red flags, and clinician contacts.

Risks and edge cases

Events that can change the plan, stay, or cost

Urinary retention or leak

Catheter removal may be delayed, or infection, leak, bleeding, or a bladder-neck issue may need treatment.

Do not book a fixed flight immediately after catheter removal.

Continence recovery

Leakage can persist and require pads, pelvic-floor therapy, medication, or further review.

Ask about rehabilitation after returning home.

Sexual function and fertility

Nerve injury, hormone therapy, age, baseline function, and treatment sequence can affect erections and fertility.

Discuss sperm preservation before treatment when relevant.

Radiation urinary or bowel effects

Frequency, bleeding, urgency, rectal symptoms, fatigue, or late tissue effects may require local care.

Know the treating team’s contact route.

Hormone complications

Hot flashes, fatigue, bone loss, diabetes, cardiovascular risk, mood, and sexual changes need monitoring.

Long-term medicine and lab costs matter.

Recurrence or progression

Rising PSA or new lesions may require imaging, biopsy, new medicines, radiation, or a changed goal.

No plan can guarantee a fixed duration.

Destination comparison

Compare India, Turkey, and Thailand for this procedure

The most suitable destination depends on the individual case, required team, treatment availability, travel route, legal eligibility, budget, and continuity after returning home.

Procedure planning comparison across India, Turkey, and Thailand
Decision factorIndiaTurkeyThailandHow to use this
Urology networkLarge metro and regional urology market with strong price variation and many robotic programs.Established private and university urology services with international surgery packages.International private services and public tertiary centers offer surgery, radiation, and systemic care.Compare pathology, imaging, technique, rehabilitation, and medicine continuity.
Pricing patternSurgery, robotic fee, radiation, and medicines may be separate.Package prices can be in TRY or foreign currency with variable inclusions.THB estimates may separate operation, device, radiation, and ongoing hormone treatment.Ask for the full first-year budget.
Regional optionSelected Tier 2 centers may provide surgery or follow-up with tertiary support.Regional centers can suit selected localized disease.Regional care may work for planned treatment if advanced imaging and referral are clear.Choose for the complete pathway.
ContinuityPractical for South Asia, Gulf, and Africa.Practical for Europe, Gulf, and Central Asia.Practical for Southeast Asia and Asian routes.Consider PSA, catheter, and medicine follow-up after travel.

Decision guidance

When Thailand may fit and when to keep comparing

Thailand may fit when

The hospital confirms grade group, stage, treatment intent, technique, radiation or medicine access, and a home PSA plan.

Seek another opinion when

The proposal offers robotic surgery without pathology review, hides hormone duration, ignores continence, or promises guaranteed sexual recovery.

Regional treatment may fit when

The named urology team, pathology, imaging, emergency service, and referral link are sufficient for the risk group.

Urgent local care comes first when

There is inability to pass urine, heavy bleeding, sepsis, severe bone pain with weakness, confusion, or rapidly worsening symptoms.

Reports for review

Prepare a case file before requesting estimates

Prepare PSA values with dates, MRI source images and report, biopsy slides or report, grade group, stage imaging, urinary and sexual baseline, prior surgery or radiation, medicines, comorbidities, fertility goals, and a treatment timeline. Ask for a written Thai proposal naming intent, technique, device, radiation or drug phases, catheter and recovery plan, THB validity, complications, and PSA handover.

Upload medical reports

Prostate evidence

PSA trend

List every PSA with date, laboratory, treatment status, and any velocity or nadir information.

MRI and biopsy

Send multiparametric MRI, targeted and systematic biopsy, grade group, cores, tumor volume, and pathology review.

Stage imaging

Include CT, bone scan, PSMA PET, MRI, and reports showing nodes, bone, or other spread.

Baseline function

Document urinary symptoms, catheter history, erectile function, bowel disease, fertility, and prior pelvic treatment.

Safety and continuity

Health history

Include heart, diabetes, kidney, clotting, anesthesia, obesity, and medication information.

Current drugs

List alpha blockers, anticoagulants, hormone medicines, steroids, supplements, and allergies.

Travel needs

Share passport, visa, companion, mobility, catheter support, housing, language, and flexible return details.

Home team

Name urologist, oncologist, PSA laboratory, pelvic-floor therapist, and emergency hospital.

Quote questions

Technique

Ask whether access is open, laparoscopic, robotic, external radiation, or brachytherapy and what devices are used.

Medicine duration

Request hormone, chemotherapy, bone, radioligand, or oral-drug names, dose, intervals, and expected months.

Recovery

Confirm catheter, continence, erectile, bowel, pelvic-floor, and early review costs.

Handover

Agree PSA schedule, pathology, prescription, recurrence plan, privacy, cancellation, and emergency terms.

Common questions

Questions about cost, travel, and follow-up

What is prostate cancer treatment cost in Thailand?

Localized surgery may be around THB 495,000 to 1,155,000, radiation and hormone care around THB 825,000 to 2,310,000, and advanced disease can exceed THB 1,320,000 to 4,950,000.

Is robotic surgery always better?

Robotic access may offer benefits for selected patients and teams, but cancer control and recovery depend on anatomy, surgeon expertise, pathology, and follow-up.

Does prostatectomy include hormone treatment?

Usually not. Hormone treatment is a separate phase unless the quotation names its drug, dose, interval, duration, and monitoring.

How long should I stay after prostatectomy?

The hospital should decide based on catheter, urine, wound, pain, mobility, infection, and travel fitness; a fixed tourist schedule is not appropriate.

Can radiation be completed in one trip?

It may require multiple sessions or a longer stay, and hormone treatment may continue at home. Confirm the exact fraction schedule.

What is the role of PSMA PET?

It can help stage higher-risk or recurrent disease when available and can alter the treatment plan, but the team decides whether it is clinically useful.

Will treatment affect erections and continence?

It can. Baseline function, nerve involvement, surgery, radiation, hormone treatment, age, and rehabilitation all influence recovery.

Can a regional city manage follow-up?

Often for selected stable care if PSA testing, medicine supply, urinary support, and a tertiary referral pathway are reliable.

What happens if PSA rises after treatment?

The team may repeat PSA, imaging, or other assessment and consider salvage radiation, hormone treatment, or another systemic option.

What records are needed for a quote?

Send PSA history, MRI, biopsy and grade group, scans, urinary and sexual baseline, prior treatment, medicines, and comorbidities.

Review and sources

How this guide was prepared

The bands separate localized prostatectomy, radiation with hormone treatment, and recurrent or metastatic care because risk group and treatment duration drive the price. The working conversion is approximately THB 33 per USD using the Bank of Thailand source checked in July 2026. The estimate includes MRI and pathology review, PSMA or stage imaging, equipment, radiation, hormone supply, continence and sexual rehabilitation, housing, and PSA continuity. The treating hospital must issue the final estimate after reviewing the full record.

This page is educational and cannot diagnose prostate cancer, choose surveillance or treatment, guarantee continence or erections, or certify a hospital’s current authorization. A urology and oncology team should review the pathology, MRI, PSA, and stage. Urinary retention, heavy bleeding, sepsis, severe weakness, or rapidly worsening pain requires urgent local care.